Raymond James & Associates’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $342K | Buy |
43,005
+4,090
| +11% | +$32.6K | ﹤0.01% | 3313 |
|
|
2024
Q2 | $326K | Sell |
38,915
-11,065
| -22% | -$92.8K | ﹤0.01% | 3301 |
|
|
2024
Q1 | $426K | Sell |
49,980
-15,713
| -24% | -$134K | ﹤0.01% | 3134 |
|
|
2023
Q4 | $558K | Sell |
65,693
-2,038
| -3% | -$17.3K | ﹤0.01% | 2877 |
|
|
2023
Q3 | $691K | Buy |
67,731
+5,125
| +8% | +$52.3K | ﹤0.01% | 2669 |
|
|
2023
Q2 | $815K | Buy |
62,606
+3,945
| +7% | +$51.3K | ﹤0.01% | 2587 |
|
|
2023
Q1 | $545K | Sell |
58,661
-34,691
| -37% | -$322K | ﹤0.01% | 2850 |
|
|
2022
Q4 | $1.02M | Buy |
93,352
+38,741
| +71% | +$422K | ﹤0.01% | 2422 |
|
|
2022
Q3 | $221K | Sell |
54,611
-6,870
| -11% | -$27.8K | ﹤0.01% | 3366 |
|
|
2022
Q2 | $448K | Buy |
61,481
+835
| +1% | +$6.08K | ﹤0.01% | 2972 |
|
|
2022
Q1 | $546K | Sell |
60,646
-13,281
| -18% | -$120K | ﹤0.01% | 3005 |
|
|
2021
Q4 | $834K | Buy |
73,927
+8,231
| +13% | +$92.9K | ﹤0.01% | 2739 |
|
|
2021
Q3 | $958K | Buy |
65,696
+11,136
| +20% | +$162K | ﹤0.01% | 2605 |
|
|
2021
Q2 | $888K | Buy |
54,560
+19,054
| +54% | +$310K | ﹤0.01% | 2666 |
|
|
2021
Q1 | $712K | Buy |
35,506
+14,066
| +66% | +$282K | ﹤0.01% | 2739 |
|
|
2020
Q4 | $441K | Sell |
21,440
-1,981
| -8% | -$40.7K | ﹤0.01% | 2880 |
|
|
2020
Q3 | $412K | Buy |
+23,421
| New | +$412K | ﹤0.01% | 2749 |
|
|
2020
Q2 | – | Sell |
-10,400
| Closed | -$100K | – | 3494 |
|
|
2020
Q1 | $100K | Buy |
+10,400
| New | +$100K | ﹤0.01% | 3193 |
|